Skorpios Trust

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Limassol, Cyprus
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Androulla Papadopoulou, Authorized Signatory on behalf of Skorpios Trust
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Skorpios Trust

Form 4 holding Former 10% owner

Akero Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,271,829
Estimated value
$2,012,175
Report date
01 Dec 2022
Price
$0.6150
Ownership
Indirect

Insider Reports Filed by Skorpios Trust

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .